PET scan usefulness in non-oncological indications assessed by Spanish AETSA

Oct 2019

In September 2019, the Andalusian Health Technology Assessment Department (AETSA) published an assessment report on the evaluation of PET scan usefulness in non-oncological indications in Spain.

The aim of this work was to structure the information related to the utility or diagnostic performance of different radiopharmaceuticals that are used in the PET for non-oncological indications established in its technical sheet. The report is based on a structured literature search with a subsequent qualitative and quantitative synthesis of obtained data. All the considered studies were grouped according to their design.

The following conclusions were provided by AETSA:

Systematic reviews with or without meta-analysis have been found for 10 of the 15 indications analyzed
The quality of systematic reviews has generally been low and, in some cases, moderate. The high-quality reviews, which conclude that routine use cannot be recommended, were found only for the indication of cognitive impairment with suspected Alzheimer's disease
Based on the localized information, AETSA suggested the preparation of an evaluation report for PET 18F-FDG in severe left ventricular insufficiency and the update of the systematic reviews for PET 18F-FDG in sarcoidosis and in refractory partial temporal epilepsy

See the full health technology assessment report in Spanish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

Rapid HTAs of five medical devices released in Tuscany

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Draft Order amending the Common Package of Benefits of the Spanish National Health System

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Belgian KCE developing procedure for assessment of digital health technologies

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Assessments of monitoring and diagnostics of atrial fibrillation products released in Sweden

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

HTAs published by FinCCHTA in February 2022

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.